|
|
Article: AUROBINDO PHARMA GETS US FDA NOD FOR HYPERTENSION DRUG.
- Article from:
- AsiaPulse News
- Article date:
- July 20, 2007
CopyrightCOPYRIGHT 2007 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW DELHI, July 20 Asia Pulse - Aurobindo Pharma Ltd (BSE:524804) on Friday announced it has received US Food and Drug Administration (US FDA) approval for its anti-hypertensive drug Amlodipine Besylate Tablets in multiple strengths.
The company got US FDA approval in 2.5 mg, 5 mg and 10 mg strengths, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Ranbaxy receives USFDA nod for Amlodipine Besylate ...
PTI - The Press Trust of India Ltd.;
June 20, 2007 ;
540 words
... ... receives USFDA nod for Amlodipine Besylate tablets Mumbai, Jun 20 (PTI) Country ... tentative approval for Amlodipine Besylate Tablets. This product represents a future ... Marketing) Jim Meehan said. Amlodipine Besylate tablets are indicated for the treatment of ...
|
|